<DOC>
	<DOC>NCT01422135</DOC>
	<brief_summary>This is a pharmacokinetics and safety study over 3 weekly applications.</brief_summary>
	<brief_title>Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females</brief_title>
	<detailed_description>Pharmacokinetic study to evaluate the safety and pharmacokinetic profile of AG200-15 following application at three different anatomical sites (abdomen, buttock and upper torso).</detailed_description>
	<criteria>Healthy women, ages 1845 years Body mass index 18 32, and weight â‰¥ 110 lbs. Willing to use a nonhormonal method of contraception if of childbearing potential, Or have already undergone previous bilateral tubal ligation or hysterectomy Willing to refrain from use of alcohol and grapefruit juice from 48 hours prior to patch application until completion of each treatment period Willing to give informed consent to participate in study Hemoglobin within normal range.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>PK and safety</keyword>
	<keyword>Pharmacokinetic profile (PK) and safety</keyword>
</DOC>